Ping Bo Selected Research

Galanin

1/2020	Galanin peptide family regulation of glucose metabolism.
3/2019	Galanin expression is down-regulated in patients with gastric cancer.
1/2019	Treatment with celastrol protects against obesity through suppression of galanin-induced fat intake and activation of PGC-1α/GLUT4 axis-mediated glucose consumption.
10/2018	Central galanin receptor 2 mediates galanin action to promote systemic glucose metabolism of type 2 diabetic rats.
12/2017	Serum Galanin Concentration is Increased in Subjects with Impaired Glucose Tolerance.
1/2017	Regulatory effects of galanin system on development of several age-related chronic diseases.
1/2017	Central injection of GALR1 agonist M617 attenuates diabetic rat skeletal muscle insulin resistance through the Akt/AS160/GLUT4 pathway.
1/2017	Beneficial effects of neuropeptide galanin on reinstatement of exercise-induced somatic and psychological trauma.
1/2016	Type 2 diabetes mellitus as a disorder of galanin resistance.
1/2016	Central Administration of Galanin Receptor 1 Agonist Boosted Insulin Sensitivity in Adipose Cells of Diabetic Rats.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ping Bo Research Topics

Disease

23	Insulin Resistance 01/2022 - 09/2012
12	Obesity 02/2020 - 08/2012
12	Type 2 Diabetes Mellitus (MODY) 02/2020 - 08/2012
9	Body Weight (Weight, Body) 01/2020 - 08/2012
8	Hyperglycemia 01/2022 - 01/2016
7	Neoplasms (Cancer) 01/2020 - 10/2011
7	Stomach Neoplasms (Stomach Cancer) 03/2019 - 01/2013
6	Glucose Intolerance 01/2020 - 10/2012
4	Coronary Stenosis (Coronary Artery Stenosis) 11/2012 - 04/2010
3	Myocardial Infarction 01/2022 - 06/2013
3	Pain (Aches) 09/2019 - 06/2013
3	Gestational Diabetes (Gestational Diabetes Mellitus) 12/2015 - 06/2013
2	Dyslipidemias (Dyslipidemia) 02/2020 - 10/2012
2	Hyperlipidemias (Hyperlipidemia) 02/2020 - 08/2012
2	Neoplasm Metastasis (Metastasis) 01/2020 - 03/2017
2	Infarction (Infarctions) 01/2019 - 04/2011
2	Overweight 03/2017 - 08/2012
2	Alzheimer Disease (Alzheimer's Disease) 01/2017 - 09/2015
2	Diarrhea 04/2016 - 01/2016
2	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 04/2016 - 01/2016
2	Hyperinsulinism (Hyperinsulinemia) 01/2016 - 12/2013
2	Hypertension (High Blood Pressure) 10/2012 - 08/2012
2	Coronary Artery Disease (Coronary Atherosclerosis) 08/2012 - 04/2010
2	Cardiovascular Diseases (Cardiovascular Disease) 04/2011 - 04/2010
2	Heart Arrest (Cardiac Arrest) 04/2011 - 04/2010
2	Pulmonary Hypertension 05/2010 - 01/2010
2	Congenital Heart Defects (Congenital Heart Defect) 05/2010 - 04/2004
2	Hypothermia 04/2004 - 02/2004
1	Alcoholic Fatty Liver 02/2020
1	Colorectal Neoplasms (Colorectal Cancer) 01/2020
1	Intervertebral Disc Degeneration 01/2020
1	Postpartum Depression (Post-Natal Depression) 09/2019
1	Weight Loss (Weight Reduction) 01/2019
1	Brain Ischemia (Cerebral Ischemia) 01/2019
1	Migraine Disorders (Migraine) 01/2019
1	Melanoma (Melanoma, Malignant) 03/2017
1	Chronic Disease (Chronic Diseases) 01/2017
1	Psychological Trauma 01/2017
1	Wounds and Injuries (Trauma) 12/2015
1	Thrombosis (Thrombus) 10/2015

Drug/Important Bio-Agent (IBA)

25	GalaninIBA 01/2020 - 08/2012
19	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 03/2013
7	NeuropeptidesIBA 10/2018 - 03/2013
7	Insulin (Novolin)FDA Link 05/2018 - 03/2013
7	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2018 - 03/2013
6	baicalinIBA 01/2022 - 01/2017
6	Proteins (Proteins, Gene)FDA Link 05/2018 - 01/2014
5	Blood Glucose (Blood Sugar)IBA 01/2018 - 09/2006
4	AntioxidantsIBA 01/2020 - 01/2014
4	Peptides (Polypeptides)IBA 01/2020 - 10/2012
4	Messenger RNA (mRNA)IBA 05/2018 - 12/2014
4	Galanin Receptors (Galanin Receptor)IBA 01/2017 - 03/2013
3	Biomarkers (Surrogate Marker)IBA 10/2016 - 04/2014
2	baicaleinIBA 02/2020 - 01/2018
2	p38 Mitogen-Activated Protein KinasesIBA 11/2019 - 01/2019
2	Pharmaceutical PreparationsIBA 01/2019 - 08/2017
2	Hypoglycemic Agents (Hypoglycemics)IBA 10/2018 - 05/2014
2	Type 1 Galanin ReceptorIBA 01/2018 - 01/2016
2	multidrug resistance-associated protein 1IBA 08/2017 - 08/2017
2	Cisplatin (Platino)FDA LinkGeneric 08/2017 - 08/2017
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2015 - 10/2011
2	alarinIBA 01/2015 - 12/2014
2	AdiponectinIBA 12/2014 - 01/2014
2	Retinol-Binding Proteins (Retinoid Binding Proteins)IBA 12/2014 - 01/2014
2	Troponin IIBA 04/2011 - 04/2010
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2011 - 04/2010
1	polycaprolactoneIBA 01/2022
1	EnzymesIBA 01/2020
1	Biliverdine (Biliverdin)IBA 01/2020
1	BilirubinIBA 01/2020
1	CateninsIBA 01/2020
1	biliverdin reductaseIBA 01/2020
1	Tuberculin (PPD)IBA 09/2019
1	PhytochemicalsIBA 05/2019
1	Gabapentin (Neurontin)FDA LinkGeneric 01/2019
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2019
1	Analgesics (Analgesic Drugs)IBA 01/2019
1	celastrolIBA 01/2019
1	Neuroprotective AgentsIBA 01/2019
1	Type 2 Galanin ReceptorIBA 01/2018
1	Long Noncoding RNAIBA 08/2017
1	kang-lai-teIBA 08/2017
1	PaxillinIBA 03/2017
1	GenisteinIBA 03/2017
1	OrexinsIBA 03/2017
1	BuffersIBA 01/2017
1	Serotonin ReceptorsIBA 04/2016
1	Melitten (Melittin)IBA 03/2016
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2016
1	human MIRN29B1 microRNAIBA 01/2016
1	MicroRNAs (MicroRNA)IBA 01/2016
1	Hormones (Hormone)IBA 12/2015
1	CalreticulinIBA 06/2015
1	wogoninIBA 06/2015

Therapy/Procedure

7	Therapeutics 06/2015 - 03/2007
6	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 11/2016 - 04/2010
2	Transplantation 01/2020 - 04/2004
2	Drug Therapy (Chemotherapy) 08/2017 - 08/2017
1	Complementary Therapies (Alternative Medicine) 09/2019
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 09/2019